Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07688395Not yet recruiting
Randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Taksim Eğitim ve Araştırma Hastanesi. Primary endpoint: Postoperative pain intensity at 24 hours. Planned start Oct 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07688395.